Related Experiment Video
Updated: May 20, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Angina pectoris in women: focus on microvascular disease
Cinzia Zuchi1, Isabella Tritto, Giuseppe Ambrosio
1Department of Cardiology, University of Perugia School of Medicine, Perugia, Italy.
Insights
Ischemic heart disease (IHD) in women is underdiagnosed and undertreated, often due to microvascular angina. New treatments show promise for improving outcomes in these patients.
Area of Science:
- Cardiology
- Women's Health
- Internal Medicine
Background:
- Ischemic heart disease (IHD) is the primary cause of death for women in Western nations, presenting with higher morbidity and mortality than in men.
- A common misconception of female protection against cardiovascular disease leads to underdiagnosis and undertreatment of IHD in women, despite their high risk for cardiovascular events.
- Women with angina pectoris often exhibit distinct characteristics, including a high prevalence of non-significant coronary artery disease and a greater likelihood of microvascular angina compared to men.
Purpose of the Study:
- To highlight the unique challenges in diagnosing and managing ischemic heart disease (IHD) in women.
- To address the suboptimal diagnostic algorithms and clinical management strategies for IHD in women, particularly those with microvascular angina.
- To underscore the need for further research and development of effective therapies for IHD in women, given their underrepresentation in clinical trials.
Main Methods:
- Review of existing literature on ischemic heart disease (IHD) in women, focusing on diagnostic challenges and treatment efficacy.
- Analysis of the pathophysiology of angina in women, emphasizing the role of microvascular dysfunction.
- Examination of clinical trial data and therapeutic responses to antianginal drugs in female populations.
Main Results:
- Standard diagnostic approaches for IHD may be suboptimal in women due to the higher prevalence of microvascular angina.
- Women with microvascular angina often remain symptomatic despite maximal therapy with traditional antianginal drugs.
- Limited representation of women in clinical trials hinders the understanding of gender-specific efficacy for antianginal medications.
Conclusions:
- Women with angina represent a distinct patient group requiring tailored diagnostic and therapeutic strategies.
- Further research is crucial to develop and validate effective treatments for IHD in women, especially those with microvascular origins.
- Concentrated efforts on improving the quality of life and reducing morbidity in women with angina are warranted.
Abstract:
Ischemic heart disease (IHD) is the leading cause of death among women in Western countries, and it is associated with higher morbidity and mortality than in men. Nevertheless, IHD in women remains underdiagnosed and undertreated, and the misperception that females are "protected" against cardiovascular disease leads to underestimation of their cardiovascular risk; instead, women with chest pain have a high risk of cardiovascular events. Women suffering from angina pectoris tend to have different characteristics compared to men, with a high prevalence of non-significant coronary artery disease. Angina in women is more commonly microvascular in origin than in men, and therefore standard diagnostic algorithms may be suboptimal for women. This different pathophysiology impacts clinical management of IHD in women. While response to medical therapy may differ in women, they are scarcely represented in clinical trials. Therefore, solid data in terms of gender efficacy of antianginal drugs are lacking, and particularly when angina is microvascular in origin women often continue to be symptomatic despite maximal therapy with classical antianginal drugs. Recently, new molecules have shown promising results in women. In conclusion, women with angina are a group of patients in whom it seems appropriate to concentrate efforts aimed at reducing morbidity and improving quality of life.
Related Concept Videos
Angina I: Introduction
Angina II: Classification
Angina V: Nursing Management
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Atherosclerosis IV: Nursing Management
